Surgical risk reduction: Prophylactic salpingo-oophorectomy and prophylactic mastectomy

Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial

Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889 · see citing works

Cancer Statistics, 2004

Jemal, A., Tiwari, R. C., Murray, T., Ghafoor, A., Samuels, A., Ward, E., Feuer, E. J., & Thun, M. J. (2004) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.54.1.8 · Cited by 3,984 · see citing works

Projecting Individualized Probabilities of Developing Breast Cancer for White Females Who Are Being Examined Annually

Gail, M. H., Brinton, L. A., Byar, D. P., Corle, D. K., Green, S. B., Schairer, C., & Mulvihill, J. J. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.24.1879 · Cited by 3,334 · see citing works

Breast and Ovarian Cancer Risks Due to Inherited Mutations in <i>BRCA1</i> and <i>BRCA2</i>

King, M.-C., Marks, J. H., & Mandell, J. B. (2003) · Science · doi:10.1126/science.1088759 · Cited by 2,229 · see citing works

Prophylactic Oophorectomy in Carriers of BRCA1 or BRCA2 Mutations

Rebbeck, T. R., Lynch, H. T., Neuhausen, S. L., Narod, S. A., Veer, L. V., Garber, J. E., Evans, D. G., Isaacs, C. J., Daly, M. B., Matloff, E. T., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012158 · Cited by 1,462 · see citing works

Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer

Hartmann, L. C., Schaid, D. J., Woods, J. E., Crotty, T. P., Myers, J. L., Arnold, P. G., Petty, P. M., Sellers, T. A., Johnson, J. L., McDonnell, S. K., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400201 · Cited by 1,428 · see citing works

Risk-Reducing Salpingo-oophorectomy in Women with aBRCA1orBRCA2Mutation

Kauff, N. D., Satagopan, J. M., Robson, M. E., Scheuer, L., Hensley, M. L., Hudis, C. A., Ellis, N. A., Boyd, J. A., Borgen, P. I., Barakat, R. R., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020119 · Cited by 1,250 · see citing works

Menopause and the Risk of Coronary Heart Disease in Women

Colditz, G. A., Willett, W. C., Stampfer, M. J., ROSNER, B. A., Speizer, F. E., & Hennekens, C. H. (1987) · New England Journal of Medicine · doi:10.1056/nejm198704303161801 · Cited by 1,153 · see citing works

Postmenopausal Hormone Replacement Therapy: Scientific Review

Nelson, H. D., Humphrey, L. L., Nygren, P., Teutsch, S. M., & Allan, J. D. (2002) · JAMA · doi:10.1001/jama.288.7.872 · Cited by 990 · see citing works

Breast Cancer after Prophylactic Bilateral Mastectomy in Women with a<i>BRCA1</i>or<i>BRCA2</i>Mutation

Meijers-Heijboer, H., van Geel, B., van Putten, W. L. J., Henzen-Logmans, S. C., Seynaeve, C., Menke-Pluymers, M. B. E., Bartels, C. C. M., Verhoog, L. C., van den Ouweland, A. M. W., Niermeijer, M. F., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107193450301 · Cited by 973 · see citing works

Overview of the main outcomes in breast-cancer prevention trials

Cuzick, J. M., Powles, T. J., Veronesi, U., Forbes, J., Edwards, R. P., Ashley, S., & Boyle, P. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12342-2 · Cited by 963 · see citing works

The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.

Lakhani, S., van de Vijver, M., Jacquemier, J., Anderson, T., Osin, P., McGuffog, L., & Easton, D. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.09.023 · Cited by 888 · see citing works

Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program.

Brose, M., Rebbeck, T., Calzone, K., Stopfer, J., Nathanson, K., & Weber, B. (2002) · Journal of the National Cancer Institute · doi:10.1093/jnci/94.18.1365 · Cited by 772 · see citing works

Efficacy of Bilateral Prophylactic Mastectomy in BRCA1 and BRCA2 Gene Mutation Carriers

Hartmann, L. C., Sellers, T. A., Schaid, D. J., Frank, T. S., Soderberg, C. L., Sitta, D. L., Frost, M. H., Grant, C. S., Donohue, J. H., Woods, J. E., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.21.1633 · Cited by 743 · see citing works

Breast Cancer Risk After Bilateral Prophylactic Oophorectomy in BRCA1 Mutation Carriers

Rebbeck, T. R., Levin, A. M., Eisen, A. F., Snyder, C., Watson, P. A., Cannon‐Albright, L., Isaacs, C. J., Olopade, O., Garber, J. E., Godwin, A. K., et al. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.17.1475 · Cited by 670 · see citing works

Oral Contraceptives and the Risk of Hereditary Ovarian Cancer

Narod, S. A., Risch, H. A., Moslehi, R., Dørum, A., Neuhausen, S. L., Olsson, H. L., Provencher, D. M., Radice, P., Evans, D. G., Bishop, S. E., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808133390702 · Cited by 612 · see citing works

Clinicopathologic features of BRCA-linked and sporadic ovarian cancer.

Boyd, J., Sonoda, Y., Federici, M. G., Bogomolniy, F., Rhei, E., Maresco, D., Saigo, P., Almadrones, L., Barakat, R., Brown, C., et al. (2000) · Journal of the American Medical Association (JAMA) · doi:10.1001/jama.283.17.2260 · Cited by 570 · see citing works

Comparison of Breast Magnetic Resonance Imaging, Mammography, and Ultrasound for Surveillance of Women at High Risk for Hereditary Breast Cancer

Warner, E., Plewes, D. B., Shumak, R. S., Catzavelos, G. C., Prospero, L. S. D., Yaffe, M. J., Goel, V., Ramsay, E. A., Chart, P., Cole, D. E. C., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.15.3524 · Cited by 461 · see citing works

Complications Leading to Surgery after Breast Implantation

Gabriel, S. E., Woods, J. E., O’Fallon, W. M., Beard, C. M., Kurland, L. T., & Melton, L. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703063361001 · Cited by 446 · see citing works

Ovarian Failure After Adjuvant Chemotherapy Is Associated With Rapid Bone Loss in Women With Early-Stage Breast Cancer

Shapiro, C. L., Manola, J. B., & LeBoff, M. S. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.14.3306 · Cited by 440 · see citing works

RECURRENT DISLOCATION OF THE SHOULDER

British Medical Journal Publishing Group (1929) · BMJ · doi:10.1136/bmj.2.3589.732 · Cited by 440 · see citing works

Outcome of Preventive Surgery and Screening for Breast and Ovarian Cancer in BRCA Mutation Carriers

Scheuer, L. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.5.1260 · Cited by 404 · see citing works

Hormonal Treatment of Postmenopausal Women

Wood, A. J. J., & Belchetz, P. E. (1994) · New England Journal of Medicine · doi:10.1056/nejm199404143301508 · Cited by 386 · see citing works

INTRA-ABDOMINAL CARCINOMATOSIS AFTER PROPHYLACTIC OOPHORECTOMY IN OVARIAN-CANCER-PRONE FAMILIES

Tobacman, J., Tucker, M., Kase, R. G., Greene, M., Costa, J. C., & Fraumeni, J. (1982) · The Lancet · doi:10.1016/s0140-6736(82)92681-2 · Cited by 351 · see citing works

BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer.

Moslehi, R., Chu, W., Karlan, B., Fishman, D., Risch, H., Fields, A., Smotkin, D., ben-David, Y., Rosenblatt, J., Russo, D., et al. (2000) · American Journal of Human Genetics · doi:10.1086/302853 · Cited by 341 · see citing works

Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation.

Meijers-Heijboer, E. J., Verhoog, L., Brekelmans, C., Seynaeve, C., Tilanus-Linthorst, M., Wagner, A., Dukel, L., Devilee, P., van den Ouweland, A. V. D., van Geel, A. V., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02347-3 · Cited by 328 · see citing works

Occult Carcinoma in Prophylactic Oophorectomy Specimens

Colgan, T. J., Murphy, J., Cole, D. E. C., Narod, S. A., & Rosen, B. P. (2001) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200110000-00009 · Cited by 327 · see citing works

Long-term Satisfaction and Psychological and Social Function Following Bilateral Prophylactic Mastectomy

Frost, M. H. (2000) · JAMA · doi:10.1001/jama.284.3.319 · Cited by 325 · see citing works

Effectiveness of Breast Cancer Surveillance in BRCA1/2 Gene Mutation Carriers and Women With High Familial Risk

Brekelmans, C. T. M., Seynaeve, C., Bartels, C. C. M., Tilanus‐Linthorst, M. M. A., Meijers-Heijboer, E. J., Crépin, C., van Geel, A. N., Menke, M., Verhoog, L. C., van den Ouweland, A., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.4.924 · Cited by 306 · see citing works

Pathologic findings in prophylactic oophorectomy specimens in high-risk women.

Leeper, K., Garcia, R., Swisher, E., Goff, B., Greer, B., & Paley, P. (2002) · Gynecologic Oncology · doi:10.1006/gyno.2002.6779 · Cited by 295 · see citing works

Differential effects of tobacco and alcohol in cancer of the larynx, pharynx, and mouth

Brugère, J., Guénel, P., Leclerc, A., & Rodriguez, J. (1986) · Cancer · doi:10.1002/1097-0142(19860115)57:2 · Cited by 289 · see citing works

Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomized study in premenopausal breast cancer patients.

Saarto, T., BLOMQVIST, C. P., Välimäki, M., Mäkelä, P. M., Sarna, S. J., & Elomaa, I. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.4.1341 · Cited by 265 · see citing works

Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing.

Lerman, C., Hughes, C., Croyle, R. T., Main, D., Durham, C., Snyder, C. L., Bonney, A., Lynch, J., Narod, S., & Lynch, H. (2000) · Preventive Medicine · doi:10.1006/pmed.2000.0684 · Cited by 262 · see citing works

A Genetic Epidemiological Study of Carcinoma of the Fallopian Tube

Aziz, S., Kuperstein, G., Rosen, B. P., Cole, D. E. C., Nedelcu, R., McLaughlin, J. R., & Narod, S. A. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2000.6095 · Cited by 221 · see citing works

American Society of Clinical Oncology Technology Assessment of Pharmacologic Interventions for Breast Cancer Risk Reduction Including Tamoxifen, Raloxifene, and Aromatase Inhibition

Chlebowski, R. T., Col, N. F., Winer, E. P., Collyar, D. E., Cummings, S. R., Vogel, V. G., Burstein, H. J., Eisen, A. F., Lipkus, I. M., & Pfister, D. G. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.06.029 · Cited by 197 · see citing works

Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis.

Paley, P., Swisher, E. M., Garcia, R., Agoff, S., Greer, B. E., Peters, K., & Goff, B. A. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2000.6071 · Cited by 193 · see citing works

Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy.

Lu, K. H., Garber, J. E., Cramer, D. W., Welch, W. R., Niloff, J., Schrag, D., Berkowitz, R., & Muto, M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.14.2728 · Cited by 188 · see citing works

Bacteria-associated hemophagocytic syndrome

Risdall, R. J., Brunning, R. D., Hernandez, J. I., & Gordon, D. (1984) · Cancer · doi:10.1002/1097-0142(19841215)54:12 · Cited by 186 · see citing works

Prophylactic oophorectomy in inherited breast/ovarian cancer families.

Struewing, J. P., Watson, P., Easton, D., Ponder, B. A. J., Lynch, H. T., & Tucker, M. A. (1995) · PubMed · Cited by 184 · see citing works

The psychosocial impact of bilateral prophylactic mastectomy: prospective study using questionnaires and semistructured

Hatcher, M. B. (2001) · BMJ · doi:10.1136/bmj.322.7278.76 · Cited by 160 · see citing works

Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer.

Eisen, A., Rebbeck, T., Wood, W., & Weber, B. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.9.1980 · Cited by 148 · see citing works

Bone Loss in Young Women With Karyotypically Normal Spontaneous Premature Ovarian Failure

Anasti, J. N. (1998) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(97)00583-8 · Cited by 147 · see citing works

Osteoporosis after Oophorectomy for Non-malignant Disease in Premenopausal Women

Aitken, J. M., Hart, D. M., Anderson, J., Lindsay, R., Smith, D. A., & Speirs, C. F. (1973) · BMJ · doi:10.1136/bmj.2.5862.325 · Cited by 142 · see citing works

Long‐term effects of oral contraceptives on ovarian cancer risk

Bosetti, C., Negri, E., Trichopoulos, D., Franceschi, S., Beral, V., Τζώνου, Α., Parazzini, F., Greggi, S., & Vecchia, C. L. (2002) · International Journal of Cancer · doi:10.1002/ijc.10696 · Cited by 119 · see citing works

The woman at increased risk for breast cancer: evaluation and management strategies

Bilimoria, M. M., & Morrow, M. (1995) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.45.5.263 · Cited by 111 · see citing works

Failure of subcutaneous mastectomy to prevent the development of breast cancer

Goodnight, J. E., Quagliana, J. M., & Morton, D. L. (1984) · Journal of Surgical Oncology · doi:10.1002/jso.2930260313 · Cited by 107 · see citing works

Ovarian cancer in women with prior hysterectomy: a 14-year experience at the University of Miami.

Sightler, S. E., Boike, G. M., Estape, R. E., & Averette, H. E. (1991) · PubMed · Cited by 104 · see citing works

Primary Breast Cancer After Prophylactic Mastectomy

Ziegler, L. D., & Kroll, S. S. (1991) · American Journal of Clinical Oncology · doi:10.1097/00000421-199110000-00018 · Cited by 103 · see citing works

Psychological impact of prophylactic oophorectomy in women at increased risk of developing ovarian cancer: a prospective study.

Tiller, K., Meiser, B., Butow, P., Clifton, M., Thewes, B., Friedlander, M., & Tucker, K. (2002) · Gynecologic Oncology · doi:10.1006/gyno.2002.6737 · Cited by 88 · see citing works

Cancer of the breast after prophylactic subcutaneous mastectomy

Eldar, S., Meguid, M. M., & Beatty, J. D. (1984) · The American Journal of Surgery · doi:10.1016/0002-9610(84)90352-0 · Cited by 84 · see citing works

Reoperations after prophylactic mastectomy with or without implant reconstruction

Zion, S. M., Slezak, J. M., Sellers, T. A., Woods, J. E., Arnold, P. G., Petty, P. M., Donohue, J. H., Frost, M. H., Schaid, D. J., & Hartmann, L. C. (2003) · Cancer · doi:10.1002/cncr.11757 · Cited by 79 · see citing works

Prophylactic oophorectomy versus screening: psychosocial outcomes in women at increased risk of ovarian cancer

Fry, A. M., Busby‐Earle, C., Rush, R., & Cull, A. (2001) · Psycho-Oncology · doi:10.1002/pon.512 · Cited by 76 · see citing works

National survey of ovarian carcinoma. I. A patient care evaluation study of the American College of Surgeons.

Averette, H. E., Hoskins, W. J., Nguyen, H. N., Boike, G. M., Flessa, H. C., Chmiel, J. S., Zuber, K., Karnell, L. H., & Winchester, D. P. (1993) · PubMed · Cited by 72 · see citing works

Risk-Reduction Mastectomy: Clinical Issues and Research Needs

Stefanek, M. E., Hartmann, L. C., & Nelson, W. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.17.1297 · Cited by 66 · see citing works

Ovarian cancer and high-risk women—implications for prevention, screening, and early detection

Modugno, F. (2003) · Gynecologic Oncology · doi:10.1016/s0090-8258(03)00254-3 · Cited by 63 · see citing works

Hysterectomy, oophorectomy, and heart disease risk factors in older women.

Kritz‐Silverstein, D. C., Barrett-Connor, E. L., & WINGARD, D. L. (1997) · American Journal of Public Health · doi:10.2105/ajph.87.4.676 · Cited by 61 · see citing works

MASTECTOMY

Hicken, N. F. (1940) · Archives of Surgery · doi:10.1001/archsurg.1940.04080010009002 · Cited by 61 · see citing works

Decision Making about Prophylactic Oophorectomy among At-Risk Women: Psychological Influences and Implications

Miller, S. M., Fang, C. Y., Manne, S. L., Engstrom, P. F., & Daly, M. B. (1999) · Gynecologic Oncology · doi:10.1006/gyno.1999.5611 · Cited by 60 · see citing works

Lipoprotein(a) and other lipids after oophorectomy and estrogen replacement therapy

Bruschi, F., Meschìa, M., Soma, M. R., PEROTTI, D., Paoletti, R., & GIORGIOCROSIGNANI, P. (1996) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(96)00349-3 · Cited by 58 · see citing works

Pharmacokinetics of oral 17 beta-estradiol.

Ra, L., & Cassidenti, D. L. (1992) · PubMed · Cited by 56 · see citing works

Uptake of screening and prevention in women at very high risk of breast cancer

Evans, D. G., Lalloo, F. I., Shenton, A., Boggis, C. R. M., & Howell, A. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06039-1 · Cited by 54 · see citing works

Deciding about prophylactic oophorectomy: what is important to women at increased risk of ovarian cancer?

Fry, A., Rush, R., Busby-Earle, C., & Cull, A. (2001) · Preventive Medicine · doi:10.1006/pmed.2001.0924 · Cited by 48 · see citing works

Subcutaneous Mastectomy: Current State of the Art

Woods, J. E. (1983) · Annals of Plastic Surgery · doi:10.1097/00000637-198312000-00016 · Cited by 39 · see citing works

Prophylactic oophorectomy and ovarian cancer surveillance. Patient perceptions and satisfaction.

Swisher, E. M., Babb, S., Whelan, A., Mutch, D. G., & Rader, J. S. (2001) · PubMed · Cited by 34 · see citing works

Effects of chemotherapy-induced castration on serum lipids and apoproteins in premenopausal women with node-positive breast cancer

Saarto, T., BLOMQVIST, C. P., Ehnholm, C., Taskinen, M., & Elomaa, I. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.12.8954058 · Cited by 33 · see citing works

Analysis of the risk reduction of prophylactic partial mastectomy in Sprague-Dawley rats with 7,12-dimethylbenzanthracene-induced breast cancer.

Jh, W., Cf, J., Swanson, J. S., Ma, P., Aa, O., Sh, M., & Ws, F. (1986) · PubMed · Cited by 32 · see citing works

Prophylactic mastectomy.

Newman, L. A., Kuerer, H., Hunt, K. K., Vlastos, G., Ames, F., Ross, M. I., & Singletary, S. (2000) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(00)00361-6 · Cited by 29 · see citing works

Screening for breast cancer with MRI

Morris, E. A. (2003) · Seminars in Ultrasound CT and MRI · doi:10.1016/s0887-2171(03)90025-4 · Cited by 27 · see citing works

Cholesterol-lowering medication, cholesterol level, and reproductive hormones in women: the women’s ischemia syndrome evaluation (WISE)

Merz, C. N. B., Olson, M. B., Johnson, B. D., Bittner, V., Hodgson, T. K., Berga, S. L., Braunstein, G. D., Pepine, C. J., Reís, S. E., Sopko, G. S., et al. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01366-9 · Cited by 25 · see citing works

Influence of bilateral oophorectomy upon lipid metabolism

Suda, Y., Ohta, H., Makita, K., Takamatsu, K., Horiguchi, F., & Nozawa, S. (1998) · Maturitas · doi:10.1016/s0378-5122(97)00089-3 · Cited by 23 · see citing works

Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia

Kern, W., Behre, G., Rudolf, T., Kerkhoff, A., Grote‐Metke, A., Eimermacher, H., Kubica, U., Wormann, B. J., Büchner, T., & Hiddemann, W. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980715)83:2 · Cited by 19 · see citing works

Variation in body fat distribution and breast cancer risk in the families of patients with breast cancer and control families

Schapira, D. V., Kumar, N. B., & Lyman, G. H. (1993) · Cancer · doi:10.1002/1097-0142(19930501)71:9 · Cited by 11 · see citing works

Prophylactic mastectomy; evolving perspectives

Sakorafas, G. H., & Tsiotou, A. G. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00343-3 · Cited by 8 · see citing works

Untitled work

(2000) · doi:10.1002/1099-1611(200011/12)9:6

Current Management Strategies for Ovarian Cancer

Aletti, G. D., Gallenberg, M. M., Cliby, W. A., Jatoi, A., & Hartmann, L. C. (2007) · Mayo Clinic Proceedings · doi:10.4065/82.6.751 · Cited by 196 · see citing works

Practice Bulletin No 182: Hereditary Breast and Ovarian Cancer Syndrome

(2017) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000002296 · Cited by 193 · see citing works

Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations

Eleje, G. U., Eke, A. C., Ezebialu, I. U., Ikechebelu, J. I., Ugwu, E. O., & Okonkwo, O. O. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012464.pub2 · Cited by 172 · see citing works

Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer

Pruthi, S., Gostout, B. S., & Lindor, N. M. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0414 · Cited by 152 · see citing works

Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers (TUBA study): a prospective non-randomised multicentre study

Harmsen, M. G., Jong, M. A.-D., Hoogerbrugge, N., Maas, A. H. E. M., Prins, J. B., Bulten, J., Teerenstra, S., Adang, E., Piek, J. M. J., van Doorn, H. C., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1597-y · Cited by 107 · see citing works

Ovarian cancer: Pathogenesis and current recommendations for prophylactic surgery

Budiana, I. N. G., Angelina, M., & Pemayun, T. G. A. (2019) · Journal of the Turkish-German Gynecological Association · doi:10.4274/jtgga.galenos.2018.2018.0119 · Cited by 77 · see citing works

Predictors of Prophylactic Bilateral Salpingo-Oophorectomy Compared With Gynecologic Screening Use in BRCA1/2 Mutation Carriers

Madalinska, J. B., van Beurden, M., Bleiker, E. M. A., Valdimarsdottir, H. B., Lubsen-Brandsma, L. A. C., Massuger, L. F. A. G., Mourits, M. J. E., Gaarenstroom, K. N., van Dorst, E. B. L., van der Putten, H. W. H. M., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.4922 · Cited by 77 · see citing works

Looking different, feeling different: women’s reactions to risk-reducing breast and ovarian surgery

kConFab Psychosocial Group on behalf of the kConFab Investigators, Hallowell, N., Baylock, B., Heiniger, L., Butow, P. N., Patel, D., Meiser, B., Saunders, C., & Price, M. A. (2012) · Familial Cancer · doi:10.1007/s10689-011-9504-4 · Cited by 66 · see citing works

Epidemiological and Genetic Factors Associated With Ovarian Cancer

McLemore, M. R., Miaskowski, C. A., Aouizerat, B. E., Chen, L.-M., & Dodd, M. J. (2009) · Cancer Nursing · doi:10.1097/ncc.0b013e31819d30d6 · Cited by 66 · see citing works

The course of distress in women at increased risk of breast and ovarian cancer due to an (identified) genetic susceptibility who opt for prophylactic mastectomy and/or salpingo-oophorectomy

Bresser, P. J. C., Seynaeve, C., Gool, A. R. V., Niermeijer, M. F., Duivenvoorden, H. J., van Dooren, S., van Geel, A. N., Menke‐Pluijmers, M. B. E., Klijn, J. G. M., & Tibben, A. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.09.009 · Cited by 63 · see citing works

The Role of Prophylactic Surgery in Cancer Prevention

You, Y. N., Lakhani, V. T., & Wells, S. A. (2007) · World Journal of Surgery · doi:10.1007/s00268-006-0616-1 · Cited by 54 · see citing works

Patient satisfaction with aesthetic outcome after bilateral prophylactic mastectomy and immediate reconstruction with implants

Gahm, J., Jurell, G., Edsander-Nord, Å., & Wickman, M. (2008) · Journal of Plastic Reconstructive & Aesthetic Surgery · doi:10.1016/j.bjps.2008.11.014 · Cited by 52 · see citing works

Peer‐support in coping with medical uncertainty: discussion of oophorectomy and hormone replacement therapy on a web‐based message board

Kenen, R. H., Shapiro, P. J., Friedman, S., & Coyne, J. C. (2007) · Psycho-Oncology · doi:10.1002/pon.1152 · Cited by 49 · see citing works

Risk-Reducing Strategies for Ovarian Cancer in BRCA Mutation Carriers: A Balancing Act

Tschernichovsky, R., & Goodman, A. (2017) · The Oncologist · doi:10.1634/theoncologist.2016-0444 · Cited by 49 · see citing works

Hereditary Breast and Ovarian Cancer Syndrome

Inuzuka, M., & Nakamura, S. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2009.02.017 · Cited by 48 · see citing works

Cost-Effectiveness of Testing for Breast Cancer Susceptibility Genes

Holland, M. L., Huston, A. J., & Noyes, K. (2008) · Value in Health · doi:10.1111/j.1524-4733.2008.00418.x · Cited by 41 · see citing works

Mindfulness‐based stress reduction for menopausal symptoms after risk‐reducing salpingo‐oophorectomy (<scp>PURSUE</scp> study): a randomised controlled trial

van Driel, C., de Bock, G., Schroevers, M., & Mourits, M. (2019) · BJOG: An International Journal of Obstetrics &amp; Gynaecology · doi:10.1111/1471-0528.15471 · Cited by 33 · see citing works

Can self-esteem, mastery and perceived stigma predict long-term adjustment in women carrying a BRCA1/2-mutation? Evidence from a multi-center study

Vodermaier, A., Esplen, M. J., & Maheu, C. (2010) · Familial Cancer · doi:10.1007/s10689-010-9325-x · Cited by 32 · see citing works

How medical choices influence quality of life of women carrying a BRCA mutation

Harmsen, M. G., Hermens, R., Prins, J. B., Hoogerbrugge, N., & de Hullu, J. A. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.07.010 · Cited by 28 · see citing works

Standard psychological consultations and follow up for women at increased risk of hereditary breast cancer considering prophylactic mastectomy

Tan, M. B., Bleiker, E. M., Menke-Pluymers, M. B., Van Gool, A. R., van Dooren, S., Van Geel, B. N., Tilanus-Linthorst, M. M., Bartels, K. C., Klijn, J. G., Brekelmans, C. T., et al. (2009) · Hereditary Cancer in Clinical Practice · doi:10.1186/1897-4287-7-6 · Cited by 27 · see citing works

FIGO position statement on opportunistic salpingectomy as an ovarian cancer prevention strategy

Mor‐Hadar, D., Wilailak, S., Berek, J. S., & McNally, O. (2024) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.15884 · Cited by 27 · see citing works

Outcomes of Concurrent Breast and Gynecologic Risk Reduction Surgery

Ma, I. T., Gray, R. J., Wasif, N., Butler, K. A., Cornella, J. L., Magrina, J. F., Magtibay, P. M., Casey, W. J., Mahabir, R. C., Rebecca, A. M., et al. (2016) · Annals of Surgical Oncology · doi:10.1245/s10434-016-5479-6 · Cited by 25 · see citing works

Hereditary cancer syndromes with high risk of endometrial and ovarian cancer: Surgical options for personalized care

McCann, G. A.-L., & Eisenhauer, E. L. (2014) · Journal of Surgical Oncology · doi:10.1002/jso.23743 · Cited by 24 · see citing works

Stopping ovarian cancer screening in BRCA1/2 mutation carriers: Effects on risk management decisions & outcome of risk-reducing salpingo-oophorectomy specimens

van Driel, C. M. G., de Bock, G. H., Arts, H. J. G., Sie, A. S., Hollema, H., Oosterwijk, J. C., & Mourits, M. J. E. (2014) · Maturitas · doi:10.1016/j.maturitas.2014.12.009 · Cited by 21 · see citing works

Factors affecting the decision to undergo risk-reducing salpingo-oophorectomy among women with BRCA gene mutation

Kim, D.-W., Kang, E., Hwang, E., Ma, S. Y., Hwang, Y., Yom, C. K., Kim, K., No, J. H., Kim, Y. B., & Kim, S. W. (2013) · Familial Cancer · doi:10.1007/s10689-013-9625-z · Cited by 20 · see citing works

Who is prone to high levels of distress after prophylactic mastectomy and/or salpingo-ovariectomy?

Bresser, P. J. C., Van Gool, A. R., Seynaeve, C., Duivenvoorden, H. J., Niermeijer, M. F., van Geel, A. N., Menke, M., Klijn, J. G. M., & Tibben, A. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm274 · Cited by 18 · see citing works

Perioperative Management of Women Undergoing Risk-reducing Surgery for Hereditary Breast and Ovarian Cancer

AlHilli, M. M., & Al-Hilli, Z. (2019) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2018.09.767 · Cited by 15 · see citing works

Ovarian Cancer Genetics and Implications for Imaging and Therapy

Elsherif, S. B., Faria, S. C., Lall, C. G., Iyer, R. B., & Bhosale, P. (2019) · Journal of Computer Assisted Tomography · doi:10.1097/rct.0000000000000932 · Cited by 15 · see citing works

Epidemiology and Etiology of Ovarian Cancer

Montes, A., Gómez, J., Viejo, M. N., Bermejo, M., Urrutia, S., & Mata, J. G. (2012) · InTech eBooks · doi:10.5772/27679 · Cited by 23 · see citing works

Gynaecological oncology perspective on management of the menopause

REES, M. C. P. (2006) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2006.03.042 · Cited by 13 · see citing works

Risk‐reducing surgery for women at high risk of epithelial ovarian cancer

Gaughan, E. M. G., & Walsh, T. (2014) · The Obstetrician & Gynaecologist · doi:10.1111/tog.12107 · Cited by 12 · see citing works

Strategies for Ovarian Cancer Prevention

Dann, R. B., Kelley, J. L., & Zorn, K. K. (2007) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2007.10.001 · Cited by 9 · see citing works

Ovarian cancer: Pathogenesis and current recommendations for prophylactic surgery

Budiana, I. N. G., Angelina, M., & Pemayun, T. G. A. (2018) · Journal of the Turkish-German Gynecological Association · doi:10.4274/jtgga.2018.0119 · Cited by 9 · see citing works

Multidisciplinary one-stage risk-reducing gynaecological and breast surgery with immediate reconstruction in BRCA-gene carrier women

Khadim, M. F., Eastwood, M. P., Price, J. H., Morrison, P. J., & Khan, K. J. (2013) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2013.09.018 · Cited by 9 · see citing works

High demoralization in a minority of oophorectomized BRCA1/2 mutation carriers influences quality of life

Jong, M. A.-D., DeJong, C. A. J., Hermens, R., Kissane, D. W., Massuger, L. F. A. G., Hoogerbrugge, N., Prins, J. B., & deHullu, J. A. (2017) · Journal of Psychosomatic Obstetrics & Gynecology · doi:10.1080/0167482x.2017.1296429 · Cited by 8 · see citing works

Scar-Free Laparoscopy in BRCA-Mutated Women

Restaino, S., Finelli, A., Pellecchia, G., Biasioli, A., Mauro, J., Ronsini, C., Martina, M. D., Arcieri, M., Corte, L. D., Sorrentino, F., et al. (2022) · Medicina · doi:10.3390/medicina58070943 · Cited by 6 · see citing works

Concurrent Prophylactic Mastectomy, Immediate Reconstruction, and Salpingo-Oophorectomy in High-Risk Patients: A Case Series

D’Abbondanza, J. A., George, R., Kives, S. L., & Musgrave, M. A. (2020) · Plastic Surgery · doi:10.1177/2292550320928551 · Cited by 5 · see citing works

Lessons from the Failure to Complete a Trial of Denosumab in Women With a Pathogenic BRCA1/2 Variant Scheduling Risk-Reducing Salpingo-Oophorectomy

Trivedi, M. S., Arber, N., Friedman, E., Garber, J. E., Holcomb, K., Horowitz, N. S., Wright, J. D., Lee, J. J., Vornik, L. A., Abutaseh, S., et al. (2022) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-22-0051 · Cited by 4 · see citing works

Psychological factors that influence decision making about prophylactic surgery

Fang, C. Y., Mckenzie, T., Miller, S. M., & Daly, M. B. (2005) · Complutensian Scientific Journals (Complutense University of Madrid) · doi:10.5209/rev_psic.2005.v2.n2.16890 · Cited by 4 · see citing works

Clinical Approach to Diagnosis and Management of Ovarian, Fallopian Tube, and Peritoneal Carcinoma

Silver, D. F., Dennis, S., & Zgheib, N. B. (2011) · Surgical pathology clinics · doi:10.1016/j.path.2010.12.003 · Cited by 3 · see citing works

Pathology results of risk‐reducing salpingo‐oophorectomy in BRCA1 /2 carriers and long‐term clinical outcomes

Assaf, W., Qarawani, A., Abboud, Y., Shalabna, E., Nahshon, C., Zilberlicht, A., Reiss, A., Schmidt, M., & Segev, Y. (2025) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.70110 · Cited by 2 · see citing works

Peritoneal cancer arising after total abdominal hysterectomy and bilateral salpingo-oophorectomy for cervical cancer in a patient with right breast cancer and germline mutation of BRCA1 gene: a case report and literature review

Harao, M., Ando, J., Kamata, H., Hoshi, N., Igarashi, S., Sekiguchi, R., & Sugano, K. (2017) · Breast Cancer · doi:10.1007/s12282-017-0813-9 · Cited by 2 · see citing works

Searching for the source: Extraovarian primary peritoneal carcinoma presenting as chest wall masses

Feng, M. B., Badiner, N. M., Hong, L., & Ioffe, Y. (2023) · Gynecologic Oncology Reports · doi:10.1016/j.gore.2023.101195 · Cited by 1 · see citing works

Changing patterns of referral into a family history clinic and detection of ovarian cancer: a retrospective 10-year review

Smallwood, K. G., Crockett, S., Huang, V., Cullimore, V., Davies, J., Satti, G., & Phillips, A. (2022) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2022.2111253 · Cited by 1 · see citing works

Prophylactic oophorectomy in patients with increased risk of ovarian cancer

Németh, K., Koppán, M., Zámbó, K., & Bódis, J. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.04.003

The Psychosocial Impact of Prophylactic Mastectomy and Salpingo-Oophorectomy

Bresser, P. J. C. (2009) · RePub (Erasmus University Rotterdam)

Impact of incidental bilateral salpingo-oophorectomy in a family member on breast cancer risk assessment: Clinical considerations

Salant, T., & Lauderdale, D. S. (2006) · Cancer Detection and Prevention · doi:10.1016/j.cdp.2006.06.004

Comparison of Gray Scale Ultrasound and POP-Q System in the Quantification of Pelvic Organ Prolapse

Gregorio, G. L., & Pangilinan, N. C. P. (2010)

Prophylactic Oophorectomy for Patients with Germline BRCA Mutations

Roque, D. R., & Dizon, D. S. (2017) · Springer eBooks · doi:10.1007/978-3-319-59198-8_5

Risk-Reducing Breast and Ovarian Surgery for Women at High Familial Risk

Schultz, I., & Sandelin, K. (2017) · Springer eBooks · doi:10.1007/978-3-319-56673-3_7

Peritoneal cancer after bilateral mastectomy, hysterectomy, and bilateral salpingooophorectomy with a poor prognosis: A case report and review of the literature

Ma, Y., Bu, H., Jin, C., Wang, X., Zhang, Y., & Zhang, H. (2019) · World Journal of Clinical Cases · doi:10.12998/wjcc.v7.i22.3872

Genetic Counseling in the Follow-up of Breast Cancer patients; Conversion of a Luminal Tumor to TNBC

Ahmadi, H., Hosseinpour, R., Jahanbin, B., Majidzadeh‐A, K., & Ardalan, F. A. (2020) · Archives of Breast Cancer · doi:10.32768/abc.20207110-13

The occurrence of ovarian cancer in the population of urban and rural women, BRCA1 and BRCA2 genes mutation testing and the general rules on the patient’s consent to treatment

Połocka-Molińska, M., Plagens-Rotman, K., Trusz, W., Gwoździcka-Piotrowska, M., Jarząbek‐Bielecka, G., Molińska-Kulesza, A., & Kędzia, W. (2021) · Pielegniarstwo XXI wieku / Nursing in the 21st Century · doi:10.2478/pielxxiw-2021-0016

Prophylactic Bilateral Salpingo-oophorectomy

Ghosh, B., Glover, A. T., & Prosser‐Snelling, E. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108582322.060

Hereditary gynecologic tumors and precision cancer medicine

Ogawa, C., Hirasawa, A., Ida, N., Nakamura, K., & Masuyama, H. (2022) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.15197

BRCA-Mutation, Ovarektomie

(2006) · Springer eBooks · doi:10.1007/978-3-540-36854-0_17

Deep ulcerated lesion on hard palate

Gonçalves, D. R., Braun, L. W., Fernandes, A. C. P., Martins, M. A. T., Martins, M. D., & Carrard, V. C. (2024) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2023.12.797

Outcomes of risk-reducing surgeries in women at high risk for gynaecological cancers: A tertiary center experience

Mor‐Hadar, D., McNally, O., Grant, A., Rajadevan, N., McBain, R. D., Naaman, Y., Chan, F., Vicario, E., & Wrede, C. D. (2025) · Surgical Oncology · doi:10.1016/j.suronc.2025.102193

Gynecologic Cancer: Risk Factors, Interception and Prevention

Samimi, G., & Heckman‐Stoddard, B. M. (2026) · Cancers · doi:10.3390/cancers18081235

Hereditary Carcinoma of the Ovary, Fallopian Tubes, and Peritoneum

Porcayo, M. A. T. (2026) · Springer eBooks · doi:10.1007/978-3-032-13454-7_35

Surgical Management of Hereditary Breast and Ovarian Cancer

Specht, M. C., Carmen, M. G. D., & Smith, B. L. (2010) · Springer eBooks · doi:10.1007/978-0-387-93846-2_4

Cirugía profiláctica como medida preventiva del cáncer de mama y ovario hereditario

Olivera, H., Cruzado, J. A., & Segura, P. (2007) · Complutensian Scientific Journals (Complutense University of Madrid) · doi:10.5209/rev_psic.2007.v4.n2.16529 · Cited by 3 · see citing works

Society of Gynecologic Oncologists Clinical Practice Committee Statement on Prophylactic Salpingo-oophorectomy

(2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2005.05.002 · Cited by 67 · see citing works

Current status of prophylactic mastectomy.

Ghosh, K., & Hartmann, L. C. (2002) · PubMed · Cited by 15 · see citing works

Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer.

Eisen, A., Rebbeck, T., Wood, W., & Weber, B. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.9.1980 · Cited by 148 · see citing works

Prophylactic oophorectomy in women at increased cancer risk

Domchek, S. M., & Rebbeck, T. R. (2007) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e32801195da · Cited by 62 · see citing works